Correction: Lutskovich et al. Comparative Preclinical Analysis of Anti-B7-H3 CAR-T Cells Targeting Neuroblastoma. Biomedicines 2025, 13, 2130

Key Points

• To evaluate the effectiveness of anti-B7-H3 CAR-T cells in targeting neuroblastoma tumors.
• Conducted a comparative preclinical analysis of different CAR-T cell therapies emphasizing anti-B7-H3.
• Assessed CAR-T cell efficacy in vitro and in vivo models of neuroblastoma.
• Analyzed immune response and tumor microenvironment interactions.
• Anti-B7-H3 CAR-T cells significantly reduced tumor growth compared to controls (p<0.05).
• Enhanced immune response observed, leading to better tumor clearance in treated models.
• Showed superior persistence of anti-B7-H3 CAR-T cells in the tumor microenvironment.